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Recently the expression ofcytotoxic CD8+ immunophenotype in severa1 cutaneous T-celllymphomas 
entities was identified. Around 5% ofmycosis fungoides (MF) may express a CD8+,CD45RA+, TlA· 
1+, CD5- (intraepitelial-pagetoid variant) or a CD8+, CD45RO+, CD5+, TlA-H (dermal, band-like 
lichenoid variant) immunophenotype and usually present large erythemato-squamòus, hycthyosiform 
plaques in tbe gluteal area or arms, showing a very indolent course as classica! NIF. Annular or 
erythemato-squamous psoriasiform lesions in tbe abdominal area or arms, with an hypochromic 
evolution and an indolent course, was characteristic ofMF in children and adolescent. In the group of 
CD30+ lymphoproliferative disorders CD8+ lymphomatoid papulosis cases were associated witb a 
PLEVA type clinical presentation, with papulo-necrotic or papulo-haemorragic blistering skin lesions 
and strong epidermotropism. Cases ofCD30+, CD8+ cutaneous anaplastic large celllymphoma were 
also observed with frequent systemic involvement and fataI outcome in 50% ofour cases. 
Subcutaneous panniculitis-like T-celllymphoma in the classical cytotoxic (CD45RO+, TlA-I +) alpha­
beta (BF-I +) variant showed an intermediate prognosis characterized by cutaneous relapses and 
possible haemophagocytic syndrome. Aggressive epidermotropic cytotoxic CD8+ T-celllymphoma 
(AeCxCD8+L) showed multiple hyperkeratotic or ulcerated nodules and plaques, with a typical CD8+, 
TIA-H, CD45RA+, CD5-/+, CD2+/- phenotype and a very aggressive fataI course. Cases of 
pleomorphic small-medium or medium-Iarge Iymphoma with an aggressive course (4 cases) or with a 
benign evolutions may be also CD8+, interestingly three ofthese aggressive cases were CD8- at 
""'--""	 presentation and positive in subsequent biopsies. Finally, very rare cases ofNKIT nasal type 
extranodallymphomas or cases ofhydroa vacciniforme-like T ce1llymphoma showing a very 
aggressive course may express CD8+, but in association with EBV strong positivity. 
Cytomorphology, immunohistochemistry and genomics must be used for tbe diagnosis and in the 
future they should be useful to better classifY CD8+ CTCLs variants. 
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